Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2017-09-18 to 2021-01-07
ROUNDS
2
led 1, joined 1
LED ROUNDS · USD
$55M
across 1 round
CO-INVESTORS
9
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2017-09-18 to 2021-01-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2021-01-07 | [ PART ] |
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $55M | 2017-09-18 | [ LEAD ] |